Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days to obtain the report for the Oncocliffe Comprehensive Cancer Panel test is typically 14 business days. However, this timeframe may vary depending on the laboratory's workload and other factors.

What are the prerequisites for the test Oncocliffe Comprehensive Cancer Panel

  • Specimen Type: FFPE tissue block or at least 10 unstained slides
  • Specimen Minimum Volume: 10 unstained slides
  • Specimen Stability: FFPE blocks and slides should be stored at room temperature
  • Specimen Rejection Criteria: Specimens received frozen, in fixatives other than formalin, or with insufficient volume
  • Shipping Requirements: Specimens should be shipped at room temperature

What are the measure values for the test Oncocliffe Comprehensive Cancer Panel

  • EGFR (Exons 18-21) - Mutation Status: Positive/Negative, Variant Allele Frequency: <2%
  • KRAS (Exons 2, 3, 4) - Mutation Status: Positive/Negative, Variant Allele Frequency: <5%
  • BRAF (Exon 15) - Mutation Status: Positive/Negative, Variant Allele Frequency: <2%
  • PIK3CA (Exons 9, 20) - Mutation Status: Positive/Negative, Variant Allele Frequency: <5%
  • PTEN (Exons 1-9) - Mutation Status: Positive/Negative, Variant Allele Frequency: <5%

What does this test Oncocliffe Comprehensive Cancer Panel identify?

  • Hereditary cancer susceptibility
  • Identification of somatic mutations in cancer-related genes
  • Assessment of tumor mutational burden
  • Predictive biomarkers for targeted therapies
  • Identification of resistance mutations in cancer

Why is this test Oncocliffe Comprehensive Cancer Panel taken?

The Oncocliffe Comprehensive Cancer Panel test is taken to analyze and identify genetic mutations that may be associated with various types of cancer. This test helps in determining personalized treatment options, predicting the risk of cancer recurrence, and identifying potential targets for therapy. By analyzing a wide range of genes known to be involved in cancer development, the Oncocliffe Comprehensive Cancer Panel provides valuable information to oncologists and healthcare providers to tailor treatment plans for individual patients.

No FAQs available.

Customer Google Rating